Show simple item record

 
dc.contributorHospital General de Granollers
dc.contributor.authorGimenez-Perez, Gabriel
dc.contributor.authorVlacho, Bogdan
dc.contributor.authorNavas, Elena
dc.contributor.authorMata-Cases, Manel
dc.contributor.authorReal, Jordi
dc.contributor.authorCos Claramunt, Francesc Xavier
dc.date.accessioned2022-09-13T07:23:18Z
dc.date.available2022-09-13T07:23:18Z
dc.date.issued2022-09
dc.identifier.citationGimenez-Perez G, Vlacho B, Navas E, Mata-Cases M, Real J, Cos X, et al. Comorbid autoimmune diseases and burden of diabetes-related complications in patients with type 1 diabetes from a Mediterranean area. Diabetes Res Clin Pract. 2022 Sep;191:110031.
dc.identifier.urihttp://hdl.handle.net/11351/8171
dc.descriptionAutoimmunity; Glycemic control; Type 1 diabetes mellitus;
dc.description.abstractAim: To assess the prevalence of autoimmune diseases (AID) in patients with type 1 diabetes (T1D) and to evaluate whether the rate of diabetes-related complications differs depending on the presence of AID. Methods: Cross-sectional analysis of 13,570 T1D patients aged ≥ 18 years registered in the SIDIAP database. The association between AID and diabetes-related complications was assessed by multivariable logistic regression models. Results: The prevalence of AID was 18.3% with thyroid AID being the most common. Patients with T1D and AID were more often female and their current age, age of diabetes onset and diabetes duration were higher. Patients with only thyroid AID experienced a lower risk of peripheral artery disease (odds ratio [OR] = 0.51, 95%; confidence interval [CI] 0.31 to 0.81) and kidney disease (OR = 0.68, 95%; 95% CI 0.54 to 0.85), whereas patients with other AID had an increased risk of ischemic heart disease (OR = 1.48, 95%; 95% CI 1.04 to 2.06). Conclusions: The burden of diabetes-related complications in patients with T1D differs according to the type of additional AID. The presence of diabetes complications is lower in those with autoimmune thyroid disease while the presence of other AID is associated with higher rates of ischemic heart disease.
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesDiabetes Research and Clinical Practice;191
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectAutoimmunitat
dc.subjectDiabetis
dc.subjectSucre - Control
dc.subject.meshAutoimmunity
dc.subject.meshDiabetes Mellitus, Type 1
dc.subject.meshDiabetes Complications
dc.titleComorbid autoimmune diseases and burden of diabetes-related complications in patients with type 1 diabetes from a Mediterranean area
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.diabres.2022.110031
dc.subject.decsautoinmunidad
dc.subject.decsdiabetes mellitus tipo I
dc.subject.decscomplicaciones de la diabetes
dc.relation.publishversionhttps://doi.org/10.1016/j.diabres.2022.110031
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.authoraffiliation[Gimenez-Perez G] Endocrinology Section, Department of Medicine, Hospital General de Granollers, Granollers, Spain. School of Medicine and Health Sciences, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Spain. [Vlacho B] DAP‑Cat group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. Institut de Recerca Hospital de la Santa Creu i Sant Pau (IIBSantPau), Barcelona, Spain. [Navas E] DAP‑Cat group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. [Mata-Cases M] DAP‑Cat group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. Primary Health Care Center La Mina, Gerència d’Atenció Primària Barcelona Ciutat, Institut Català de la Salut, Sant Adrià de Besòs, Spain. [Real J] DAP‑Cat group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. Primary Health Care Center La Mina, Gerència d’Atenció Primària Barcelona Ciutat, Institut Català de la Salut, Sant Adrià de Besòs, Spain. [Cos X] DAP‑Cat group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. Primary and Hospital Innovation Department, Innovation Office at Institut Català de la Salut, Barcelona, Spain
dc.identifier.pmid35934173
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record